LINKÖPING, Sweden and
PARIS, March 25, 2021 /PRNewswire/ -- GHU Paris
psychiatrie & neurosciences has ordered a digital
pathology solution from international medical imaging IT and
cybersecurity company Sectra (STO: SECT B). The digital
technology will maximize workflow efficiency and improve
collaboration between pathologists, pushing the limits even further
within the field of neuropathology. This will ultimately lead to
more accurate and faster diagnoses for patients, which is key when
deciding on a suitable treatment, especially in precision medicine.
"As an expert center in neuropathology, we process a high volume
of second readings from other centers, especially within rare
tumors. Having access to image analysis tools is therefore a huge
advantage for us. With Sectra, we now have these tools in hand, and
because the solution is easy to use, our pathologists will be able
to utilize the benefits from day one," says Professor Pascale Varlet, pathologist at GHU Paris
psychiatrie & neurosciences.
Brain tissue samples analyzed by GHU Paris are either collected
at their own site or received from other hospitals. By scanning
tissue samples to digital images instead of using physical glass
slides, pathologists can access and share current and historical
images and information from anywhere at any time. Furthermore,
Sectra's solution provides pathologists with assistance at critical
decision points, such as grading or performing more precise
measurements. It also enables image analysis, which in turn reduces
variation and improves the precision of tasks such as cell
counting.
"Digital pathology is taking off in France. I'm excited to support GHU Paris in
their journey as one of the early adopters and proud that Sectra
has once again been chosen to help drive the field forward.
Ultimately, digitization will bring so many benefits to, for
example, cancer patients," says Fabien
Lozach, Managing Director of Sectra in France.
Once live with the system, GHU Paris will also be able to
increase efficiency during multidisciplinary tumor board meetings
(MDTs) since a digital setting makes it possible to display
different types of patient data side by side and thereby provide
more meaningful discussions. Furthermore, there will no longer be a
need to meet physically during MDTs. This is a big advantage for
GHU Paris since they are in close contact with pathologists and
doctors at other hospitals as part of their participation in
RENOCLIP, a national network managing rare tumors of the central
nervous system.
The contract was signed during the third quarter of Sectra's
2020/2021 fiscal year.
Sectra's pathology solution is part of its enterprise imaging
offering. It provides a unified strategy for all imaging needs
while lowering operational costs. The scalable and modular
solution, with a VNA at its core, allows healthcare providers to
grow from ology to ology and from enterprise to enterprise. Read
more about Sectra's enterprise imaging solution and why Sectra PACS
has been ranked "Best in KLAS" for seven consecutive years at
medical.sectra.com.
About GHU Paris psychiatrie & neurosciences
GHU Paris psychiatrie & neurosciences was founded on
January 1, 2019, following the merger
of three hospitals: Maison Blanche,
Perray-Vaucluse and Sainte-Anne. With a total of 60,000 active
patients, GHU Paris's services are used by one in 40 Parisians. GHU
Paris's neuropathology unit is part of the Neuro-St-Anne clinic and
collaborates closely with the hospitals affiliated with Paris
Descartes University: Cochin,
Necker and HEGP. GHU Paris is an expert center in neuroscience and
is part of RENOCLIP, a national network specializing in rare tumors
of the central nervous system. For more information, visit
ghu-paris.fr
About Sectra
Sectra assists hospitals throughout the world to enhance the
efficiency of care, and authorities and defense forces in
Europe to protect society's most
sensitive information. Thereby, Sectra contributes to a healthier
and safer society. The company was founded in 1978, has its head
office in Linköping, Sweden, with
direct sales in 19 countries, and operates through partners
worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on
the Nasdaq Stockholm exchange. For more information, visit
sectra.com.
For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705
23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and
President Sectra Imaging IT Solutions, +46 (0)708 23 56 10
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/sectra/r/french-hospital-specialized-in-neuroscience-chooses-sectra-s-digital-pathology-solution-to-improve-d,c3313628
The following files are available for download:
https://news.cision.com/sectra/i/sectra-digital-pathology,c2892855
|
Sectra Digital
Pathology
|